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From Research to Clinical Use
Are We Getting Closer?*Thor Edvardsen, MD, PHD,yzx Kristina H. Haugaa, MD, PHDyzxT he ability to imagine a 3-dimensional (3D)image of the heart was one of the earliestrecognized beneﬁts of 2-dimensional (2D)
echocardiography at its inception 40 years ago. The
ability to build such an image in real time has been
a remarkable feat of image processing in the past
decade. Intuitively, 3D imaging is the future of echo-
cardiography, and the superiority of this method
compared with 2D techniques is most apparent in
the assessment of structural abnormalities (e.g.,
valvular heart disease and septal defects). In addition
to these rendered images, quantitation of volume-
based measurements, such as ejection fraction (EF),
is better performed by 3D than with 2D echocardio-
graphic techniques. After its development in 2D echo-
cardiography, measurement of myocardial strain has
recently been implemented in 3D echocardiography
by multiple vendors. However, even though the 3D
strain technique has been available for some years,
many experts have considered that it was not yet
ready for clinical implementation.SEE PAGE 235In this issueof iJACC, Nagata et al. (1) present theutility
of 3D strain to predict adverse events in asymptomatic
patients with severe aortic stenosis and preserved EF.
The correct timing of aortic valve replacement (AVR) is
debated in this patient group, for whomwatchful waiting
is widely used. However, the risk of an expectant*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
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deterioration of cardiac function and sudden death (2).
Although estimating the risks of these events is difﬁcult,
statisticalmodeling has suggested that riskwouldhave to
be an order of magnitude higher than currently reported
to justify intervention (3). Several attempts have been
made to predict an adverse outcome, including assess-
ment of biomarkers and echocardiographic studies.
Nagata et al. (1) studied 114 patients with 2D and 3D strain
and showed encouraging results for 3D strain. This mo-
dality was the best predictor of an adverse outcome and
also had predictive value for mortality. Furthermore, 3D
strain was marginally better compared with 2D global
longitudinal strain to predict adverse outcomes also in
patients with low-gradient, severe aortic stenosis, a
condition that is particularly challenging to evaluate.
The current study is one of the ﬁrst to report
potential clinical beneﬁts by using 3D strain imaging
and may facilitate the use of 3D strain in clinical
practice. The theoretical advantages of 3D strain are
acquisition of full volume from 1 probe position
and software that can follow speckles in 3 dimen-
sions. The obvious disadvantages are image quality
(including stitching defects), limited validation
studies and deﬁnition of normal values, low temporal
and spatial resolution, and even higher variability
among vendors, similar to problems with 2D strain. In
patients with severe aortic stenosis and preserved EF,
the advantage of 3D strain in assessing the total left
ventricular function may be of particular importance.
As shown in several studies, EF has excellent
prognostic value in those with reduced cardiac func-
tion, but has limited prognostic value in those with
relatively preserved cardiac function. The additional
and prognostic information of 2D myocardial strain in
patients with preserved EF was shown previously
(4,5), and 3D strain might possess similar or even
better prognostic value in patients with a normal EF.
As always in medicine, intervention decisions should
rarely rely on only 1 single parameter. With regard to
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 3 , 2 0 1 5 Edvardsen and Haugaa
M A R C H 2 0 1 5 : 2 4 6 – 7 Editorial Comment
247AVR timing in asymptomatic patients with severe
aortic stenosis, 3D echocardiography might provide
guidance as to when patients should be scheduled for
early intervention and when watchful waiting may be
a safe alternative.
This paper provides us with encouraging informa-
tion about the value of 3D strain in this setting, but is
it enough to change guidelines or practice? Probably
not. A weakness of the study is that AVR was included
as an adverse event, and therefore, the natural his-
tory in these aortic stenosis patients can only be
speculated on. Second, the selection process to ﬁnd
suitable studies of adequate quality seemed onerous;
429 patients underwent 3D echocardiography, 133
met inclusion criteria, and 104 entered the study.
Third, the correlation between 2D and 3D global
longitudinal strain was only modest (r ¼ 0.56), which
seems troubling for 2 ways of measuring the same
process. Fourth, and perhaps most important, we
read of a 4% to 5% intraobserver variation and a 5% to
7% interobserver variation from the same images, but
what we want to know relates to test-retest variation
(i.e., repeat images). Previous papers have reported
only moderate performance of this parameter, with
discrepancies with 2D strain being most prominent
when 3D strain was gathered at low temporal reso-
lution (6). Finally, this study included a relativelysmall number of patients with short follow-up, and
the superiority of 3D strain over 2D strain was only
marginal. Before implementation of 3D strain in
clinical practice, further studies should conﬁrm the
results of Nagata et al. (1).
The medical community is conservative and pre-
fers well-documented methods. The time from the
ﬁrst research results to clinical acceptance can be
long, as exempliﬁed by the calculation of cardiac
output by Doppler measurements, which we regard
as a standard measure today (7). It took more than
10 years after the ﬁrst report before that method was
generally accepted in clinical practice. Thorny ways
to clinical acceptance should therefore not
discourage further studies and developments in 3D
strain. Better image quality and processing power
and more user-friendly software will obviously
further improve these methods. At this stage, we
should be patient and wait for these improvements
before 3D strain can be widely accepted and included
in our daily practice.
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